Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Research firm
Operon Research
Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q3 (9 quarters).
- Questions
- 87on tracked calls
- Challenge rate
- 2%2 of 87 questions
- Analysts
- 1with at least one question
- Companies
- 11questioned at least once
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Analysts
Most questions first. Each challenge rate shows the exact count behind it.
| Analyst | Companies | Questions | Challenge rate |
|---|---|---|---|
| Jack Meehan | 11 | 87 | 2%2 of 87 questions |
- Jack Meehan11 companies · 87 questions2%2 of 87 questions
Companies
Most questions first, counting every analyst at this firm.
- TMOThermo Fisher Scientific13 questions
- AAgilent Technologies11 questions
- DHRDanaher Corporation10 questions
- LHLabCorp10 questions
- WATWaters Corporation10 questions
- MTDMettler Toledo9 questions
- HOLXHologic8 questions
- DGXQuest Diagnostics7 questions
- ILMNIllumina, Inc.5 questions
- IQVIQVIA3 questions
- RVTYRevvity1 question
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Analysts | Companies |
|---|---|---|---|---|
| 2024 Q3 | 2 | 0%none of 2 questions | 1 | 1 |
| 2024 Q4 | 15 | 0%none of 15 questions | 1 | 8 |
| 2025 Q1 | 14 | 0%none of 14 questions | 1 | 8 |
| 2025 Q2 | 13 | 0%none of 13 questions | 1 | 8 |
| 2025 Q3 | 11 | 0%none of 11 questions | 1 | 7 |
| 2025 Q4 | 13 | 0%none of 13 questions | 1 | 8 |
| 2026 Q1 | 8 | 0%none of 8 questions | 1 | 6 |
| 2026 Q2 | 10 | 20%2 of 10 questions | 1 | 8 |
| 2026 Q3 | 1 | 0%none of 1 question | 1 | 1 |
- 2024 Q32 questions · challenge rate 0% (none of 2 questions) · 1 analyst · 1 company
- 2024 Q415 questions · challenge rate 0% (none of 15 questions) · 1 analyst · 8 companies
- 2025 Q114 questions · challenge rate 0% (none of 14 questions) · 1 analyst · 8 companies
- 2025 Q213 questions · challenge rate 0% (none of 13 questions) · 1 analyst · 8 companies
- 2025 Q311 questions · challenge rate 0% (none of 11 questions) · 1 analyst · 7 companies
- 2025 Q413 questions · challenge rate 0% (none of 13 questions) · 1 analyst · 8 companies
- 2026 Q18 questions · challenge rate 0% (none of 8 questions) · 1 analyst · 6 companies
- 2026 Q210 questions · challenge rate 20% (2 of 10 questions) · 1 analyst · 8 companies
- 2026 Q31 question · challenge rate 0% (none of 1 question) · 1 analyst · 1 company
Topics and sectors
Topics tagged on this firm’s questions
- Demand36
- Revenue Growth24
- M&A15
- Margin14
- Regulation Policy12
- Guidance Reliability11
- Trade Tariffs10
- Competitive Dynamics7
- Capital Allocation7
- Cost Pressure5
Show all 18 topics
- Innovation & R&D5
- Product Launch5
- Pricing4
- Macroeconomic4
- Cloud & AI3
- Capex Investment3
- Geographic Expansion2
- Inventory1
Questions by company sector
- Healthcare87